Our keynote speaker for PMA 2020 is Leroy "Lee" Hood, MD, PhD, SVP and Chief Science Officer, Providence St. Joseph Health; Chief Strategy Officer, Co-founder and Professor, Institute for Systems Biology (ISB).  Dr. Hood is pillar in the biotechnology field and a world leader in Personalized Medicine.

Wednesday, March 11, 2020

4:00pm - 6:00pm          Check-in and registration
6:00pm - 8:00pm          Welcome reception and Networking

* speakers names will be added to the program as they are confirmed

Thursday, March 12, 2020

7:00am             Continental Breakfast
8:00am             Welcome Conference Chairs: Kevin Deane, MD, PhD and Liron Caplan, MD, PhD, University of Colorado
8:10am              Keynote Address: Precision medicine: past, present and future, Lee Hood, MD/PhD, Institute for Systems Biology

TOPIC AREA - Management of Rheumatoid Arthritis (RA)
9:00am             How to select the right drug at the right time for the right patient with RA?  Costantino Pitzalis MD, PhD, Barts and the London School of Medicine and Dentistry
9:30am             Unmet needs in RA clinical trials – academic perspective, Jim O'Dell, MD, University of Nebraska
10:00am           Unmet needs in RA clinical trials - industry perspective, Jeremy Sokolove, MD

10:30am           Break

TOPIC AREA - Novel biomarkers in RA 
10:45am           Anti-Malondialdehyde-acetaldehyde adducts (MAA) in RA and RA-Interstitial lung disease (ILD), Ted Mikuls, MD, MSPH, University of Nebraska

11:15am           Proteomics and the natural history of RA, Liam O'Neil, MD, University of Manitoba

TOPIC AREA - Clinical cohorts to improve precision medicine
11:45am          American College of Rheumatology RISE Registry (adult), Jinooz Yazdany, MD University of California San Francisco

12:15pm          Lunch

 1:00pm            CARRA (pediatric), Robert Fuhlbrigge, MD, PhD, Children's Hospital Colorado
 1:30pm          Moving from Trial and Error to Precision Decisions in Childhood Arthritis – Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease (UCAN CANDU), Deborah Marshall, PhD, University of Calgary
TOPIC AREA - Psoriatic Arthritis
2:00pm            Prevention in psoriatic arthritis, Christopher Ritchlin, MD, University of Rochester

TOPIC AREA - SLE and Sjogren's Syndrome, part 1
2:30pm           Clinical decision-making tools in SLE, Jasvinder Singh, MD, University of Birmingham

3:00pm           Break

TOPIC AREA - Precision Medicine in Inflammatory Bowel Disease
3:15pm            Prediction and prevention in inflammatory bowel disease, Marla Dubinsky, MD, Mount Sinai, NY   
3:45pm            Diagnosis and therapy optimization in inflammatory bowel disease, Dermot McGovern, MD, Cedars-Sinai

TOPIC AREA - SLE and Sjogren's Syndrome, part 2
4:15pm           Unmet needs in clinical trials in SLE, Mary Crow, MD, Hospital for Special Surgery, NY
4:45pm            Molecular classification of Sjogren's syndrome: new insights and opportunities, Judith James, MD, PhD, Oklahoma Medical Research Foundation

5:15pm            Abstract presentation  
5:25pm            Abstract presentation 
5:35pm            Abstract presentation
5:45pm            Abstract presentation  
6:00pm            Summary/Wrap-up, Marvin Pritzler, MD/PhD, University of Calgary

Friday, March 13, 2020

7:00am             Continental Breakfast
7:30am             Welcome/Announcements

TOPIC AREA - Spondyloarthritis and psoriasis-psoriatic arthritis  
7:40am             New guidelines for treatment of spondyloarthritis: methods of development and opportunities and challenges in precision medicine, Liron Caplan, MD, PhD, University of Colorado
8:10am             Early identification of psoriatic arthritis and optimizing initial therapy, Alexis Ogdie, MD, University of Pennsylvania
TOPIC AREA - Tools in evaluating autoimmunity  
8:40am             Artificial intelligence and imaging in inflammatory arthritis and lupus, Ogla Kubasskova, PhD, Image Analysis Group
9:10am             Beyond PASI: advances in artificial vision and telemedicine to diagnosis and manage psoriasis, April Armstrong, MD, MPH, Keck School of Medicine of University of Southern California

9:40am             Break

TOPIC AREA - Myositis and Systemic Sclerosis
10:00am           Autoantibodies in the diagnosis and classification of patients with myositis, Christopher Mecoli, MD Johns Hopkins
10:30am           Biomarker prediction of cancer and ILD in myositis, Rohit Aggarwal, MD, University of Pittsburgh
11:00am            Autoantibodies in the diagnosis and classification of patients with systemic sclerosis (including ILD and cancer)
11:30am           Lunch

TOPIC AREA - Patient-related factors in precision medicine
 12:30pm           Lifestyle modifications and management of autoimmune disease – precision medicine based on modifiable factors, David Furman, PhD, Stanford University
1:00pm              Updates on PRO’s in management of patients with autoimmune diseases, Vibeke Strand, MD, Stanford University           
TOPIC AREA - Evolving concepts in precision medicine in autoimmunity
1:30pm              Complement therapy in rheumatic diseases, V. Michael Holers, MD, University of Colorado
2:00pm             Checkpoint inhibitors: prediction, prevention and treatment from a rheumatologist perspective, Len Calabrese, DO, Cleveland Clinics
2:30pm             Seen and Heard at this Meeting: Promises, Pitfalls and Challenges of Precision Medicine in Autoimmune Diseases, Marvin Fritzler, MD, PhD, University of Calgary
3:00pm             Panel Discussion
3:30pm              Wrap-up/Concluding Remarks